Correlation Between Dreyfus Technology and Biotechnology Fund
Can any of the company-specific risk be diversified away by investing in both Dreyfus Technology and Biotechnology Fund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dreyfus Technology and Biotechnology Fund into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dreyfus Technology Growth and Biotechnology Fund Class, you can compare the effects of market volatilities on Dreyfus Technology and Biotechnology Fund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dreyfus Technology with a short position of Biotechnology Fund. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dreyfus Technology and Biotechnology Fund.
Diversification Opportunities for Dreyfus Technology and Biotechnology Fund
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dreyfus and BIOTECHNOLOGY is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Dreyfus Technology Growth and Biotechnology Fund Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Fund Class and Dreyfus Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dreyfus Technology Growth are associated (or correlated) with Biotechnology Fund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Fund Class has no effect on the direction of Dreyfus Technology i.e., Dreyfus Technology and Biotechnology Fund go up and down completely randomly.
Pair Corralation between Dreyfus Technology and Biotechnology Fund
Assuming the 90 days horizon Dreyfus Technology Growth is expected to generate 1.29 times more return on investment than Biotechnology Fund. However, Dreyfus Technology is 1.29 times more volatile than Biotechnology Fund Class. It trades about 0.09 of its potential returns per unit of risk. Biotechnology Fund Class is currently generating about 0.04 per unit of risk. If you would invest 5,266 in Dreyfus Technology Growth on August 31, 2024 and sell it today you would earn a total of 2,800 from holding Dreyfus Technology Growth or generate 53.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.73% |
| Values | Daily Returns |
Dreyfus Technology Growth vs. Biotechnology Fund Class
Performance |
| Timeline |
| Dreyfus Technology Growth |
| Biotechnology Fund Class |
Dreyfus Technology and Biotechnology Fund Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dreyfus Technology and Biotechnology Fund
The main advantage of trading using opposite Dreyfus Technology and Biotechnology Fund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dreyfus Technology position performs unexpectedly, Biotechnology Fund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Fund will offset losses from the drop in Biotechnology Fund's long position.| Dreyfus Technology vs. Tiaa Cref Real Estate | Dreyfus Technology vs. Guggenheim Risk Managed | Dreyfus Technology vs. Us Real Estate | Dreyfus Technology vs. Commonwealth Real Estate |
| Biotechnology Fund vs. Vy T Rowe | Biotechnology Fund vs. Eaton Vance Atlanta | Biotechnology Fund vs. Blackrock Health Sciences | Biotechnology Fund vs. Blackrock Health Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |